Treatment of Elderly Cancer Patients - An Untapped Market Opportunity

Introduction

Currently elderly people have a higher incidence of the four major tumor types than any other age group, yet there is a fundamental lack of knowledge regarding the treatment of elderly cancer patients, resulting in their under-treatment. This means that elderly cancer patients form an untapped market opportunity for healthcare providers and pharmaceutical manufacturers. 

Scope

An overview of the epidemiology of four main tumor types amongst the elderly. 

Discussions concerning the problems associated with clinical trials and the treatment of elderly cancer patients. 

An overview of the different methods of treatment used in elderly patients. 

Case studies of breast and lung cancer treatment in the elderly. 

Report Highlights

There is a fundamental lack of knowledge regarding the treatment of elderly cancer patients, resulting in under-treatment. Datamonitor recommends that pharmaceutical companies research treatment strategies aimed specifically at elderly patients to encourage higher prescribing levels.

Reasons to Purchase

Define the size of the elderly cancer market 

Identify the key areas of development in NSCLC and breast cancer treatment for elderly patients 

Understand the importance of targeting your therapies to the elderly cancer population 

Publisher: Datamonitor Oncology Reports 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_Oncology.html#a253